Financhill
Back

Catalyst Pharmaceuticals Vs. BioVie Industry Stock Comparison

Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
21.91
Seasonality Move:
1.7%
Sell
39

BIVI
BioVie

Last Price:
2.80
Seasonality Move:
18.19%
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.19. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
BioVie (BIVI) is a Sell

Is BioVie a Buy, Sell or Hold?

  • The current BioVie [BIVI] share price is $3.00. The Score for BIVI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

BIVI Stock Price Chart

What is BioVie's stock price today?

  • The BioVie share price today is $3.00
    The current trend is moderately bearish and BIVI is experiencing slight selling pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 46.25 Sell
Chaikin Money Flow: -786667 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.05 - 22.71) Sell
Bollinger Bands (100): (17.71 - 21.73) Buy

BIVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 53.77 Buy
Chaikin Money Flow: -510549 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.62 - 3.28) Buy
Bollinger Bands (100): (1.88 - 3.82) Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.18 Buy
20-day SMA: 21.97 Sell
50-day SMA: 21.13 Buy
200-day SMA: 17.61 Buy
8-day EMA: 21.43 Sell
20-day EMA: 21.62 Sell
50-day EMA: 21.07 Buy
200-day EMA: 18.28 Buy

BIVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.23 Sell
20-day SMA: 2.96 Buy
50-day SMA: 2.32 Buy
200-day SMA: 4.57 Sell
8-day EMA: 3.14 Sell
20-day EMA: 2.96 Buy
50-day EMA: 2.72 Buy
200-day EMA: 7.57 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

BioVie Earnings Growth & BIVI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):